» Articles » PMID: 16796380

Cannabinoid Receptors and Endocannabinoids: Evidence for New Players

Overview
Journal AAPS J
Specialty Pharmacology
Date 2006 Jun 27
PMID 16796380
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

It is now well established that the psychoactive effects of Cannabis sativa are primarily mediated through neuronal CB1 receptors, while its therapeutic immune properties are primarily mediated through CB2 receptors. Two endocannabinoids, arachidonoylethanolamide and 2-arachidonoylglycerol, have been identified, their action on CB1 and CB2 thoroughly characterized, and their production and inactivation elucidated. However, many significant exceptions to these rules exist. Here we review the evidence suggesting that cannabinoids can modulate synaptic transmission, the cardiovascular system, and the immune system through receptors distinct from CB1 and CB2, and that an additional "independent" endocannabinoid signaling system that involves palmitoylethanolamide may exist.

Citing Articles

Possible Combinatorial Utilization of Phytochemicals and Extracellular Vesicles for Wound Healing and Regeneration.

Koyama S, Weber E, Heinbockel T Int J Mol Sci. 2024; 25(19).

PMID: 39408681 PMC: 11476926. DOI: 10.3390/ijms251910353.


Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants.

Kelly L, Rieder M, Finkelstein Y Paediatr Child Health. 2024; 29(2):104-121.

PMID: 38586491 PMC: 10996578. DOI: 10.1093/pch/pxad077.


Medical cannabis for children: Evidence and recommendations.

Kelly L, Rieder M, Finkelstein Y Paediatr Child Health. 2024; 29(2):104-121.

PMID: 38586483 PMC: 10996577. DOI: 10.1093/pch/pxad078.


Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses.

Eichler F, Pozniak B, Machnik M, Schenk I, Wingender A, Baudisch N Front Vet Sci. 2023; 10:1234551.

PMID: 37621871 PMC: 10445762. DOI: 10.3389/fvets.2023.1234551.


How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases.

Dziemitko S, Harasim-Symbor E, Chabowski A Ther Adv Chronic Dis. 2023; 14:20406223221143239.

PMID: 36636553 PMC: 9830002. DOI: 10.1177/20406223221143239.


References
1.
Breivogel C, Griffin G, Di Marzo V, Martin B . Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol. 2001; 60(1):155-63. View

2.
Cravatt B, Demarest K, Patricelli M, Bracey M, Giang D, Martin B . Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A. 2001; 98(16):9371-6. PMC: 55427. DOI: 10.1073/pnas.161191698. View

3.
Stella N, Piomelli D . Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol. 2001; 425(3):189-96. DOI: 10.1016/s0014-2999(01)01182-7. View

4.
Ueda N, Yamanaka K, Yamamoto S . Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem. 2001; 276(38):35552-7. DOI: 10.1074/jbc.M106261200. View

5.
Hajos N, Ledent C, Freund T . Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience. 2001; 106(1):1-4. DOI: 10.1016/s0306-4522(01)00287-1. View